Back to Search Start Over

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization

Authors :
Luciano Cascione
Luca Giudice
Serena Ferraresso
Laura Marconato
Diana Giannuzzi
Sara Napoli
Francesco Bertoni
Rosalba Giugno
Luca Aresu
Source :
Non-Coding RNA, Vol 5, Iss 3, p 47 (2019)
Publication Year :
2019
Publisher :
MDPI AG, 2019.

Abstract

Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic behavior, tumor genetics, and treatment response. The molecular mechanisms that underlie canine BCL are still unknown and new studies to improve diagnosis, therapy, and the utilization of canine species as spontaneous animal tumor models are undeniably needed. Recent work using human DLBCL transcriptomes has suggested that long non-coding RNAs (lncRNAs) play a key role in lymphoma pathogenesis and pinpointed a restricted number of lncRNAs as potential targets for further studies. Results: To expand the knowledge of non-coding molecules involved in canine BCL, we used transcriptomes obtained from a cohort of 62 dogs with newly-diagnosed multicentric DLBCL, MZL and FL that had undergone complete staging work-up and were treated with chemotherapy or chemo-immunotherapy. We developed a customized R pipeline performing a transcriptome assembly by multiple algorithms to uncover novel lncRNAs, and delineate genome-wide expression of unannotated and annotated lncRNAs. Our pipeline also included a new package for high performance system biology analysis, which detects high-scoring network biological neighborhoods to identify functional modules. Moreover, our customized pipeline quantified the expression of novel and annotated lncRNAs, allowing us to subtype DLBCLs into two main groups. The DLBCL subtypes showed statistically different survivals, indicating the potential use of lncRNAs as prognostic biomarkers in future studies. Conclusions: In this manuscript, we describe the methodology used to identify lncRNAs that differentiate B-cell lymphoma subtypes and we interpreted the biological and clinical values of the results. We inferred the potential functions of lncRNAs to obtain a comprehensive and integrative insight that highlights their impact in this neoplasm.

Details

Language :
English
ISSN :
2311553X
Volume :
5
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Non-Coding RNA
Publication Type :
Academic Journal
Accession number :
edsdoj.f8ce2029dcd948c2a93001d5f2088669
Document Type :
article
Full Text :
https://doi.org/10.3390/ncrna5030047